Total Payments
$7,792
2024 Payments
$949.30
Companies
36
Transactions
391
Medicare Patients
815
Medicare Billing
$55,562
Payment Breakdown by Category
Food & Beverage$7,722 (99.1%)
Education$69.94 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,722 | 386 | 99.1% |
| Education | $69.94 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,225 | 108 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,270 | 68 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $391.16 | 29 | $0 (2024) |
| Olympus America Inc. | $345.70 | 6 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $298.49 | 15 | $0 (2018) |
| Celgene Corporation | $281.43 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $270.73 | 7 | $0 (2020) |
| Gilead Sciences, Inc. | $266.61 | 14 | $0 (2023) |
| Janssen Biotech, Inc. | $244.51 | 19 | $0 (2024) |
| Allergan Inc. | $223.02 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $949.30 | 39 | AIMMUNE THERAPEUTICS, INC. ($168.32) |
| 2023 | $1,015 | 46 | AbbVie Inc. ($395.08) |
| 2022 | $1,292 | 62 | ABBVIE INC. ($397.04) |
| 2021 | $949.38 | 56 | AbbVie Inc. ($438.10) |
| 2020 | $514.81 | 34 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($205.41) |
| 2019 | $1,096 | 56 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($253.94) |
| 2018 | $1,067 | 50 | AbbVie, Inc. ($355.72) |
| 2017 | $908.58 | 48 | AbbVie, Inc. ($172.01) |
All Payment Transactions
391 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/11/2024 | EVOKE PHARMA, INC. | — | Food and Beverage | In-kind items and services | $24.44 | General |
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $0.70 | General |
| 09/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: Neuroscience | ||||||
| 08/22/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| 08/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $124.38 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/27/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/24/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $74.65 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/20/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $79.56 | General |
| Category: General - Hemostasis_ENDO | ||||||
| 06/03/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $10.70 | General |
| 05/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $94.22 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 165 | 178 | $20,815 | $11,886 |
| 2022 | 3 | 180 | 198 | $22,820 | $13,126 |
| 2021 | 6 | 265 | 286 | $33,990 | $19,333 |
| 2020 | 7 | 205 | 217 | $40,840 | $11,217 |
Total Patients
815
Total Services
879
Medicare Billing
$55,562
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 111 | $11,100 | $6,936 | 62.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 67 | 67 | $9,715 | $4,949 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 102 | $10,200 | $6,677 | 65.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 83 | 83 | $12,035 | $6,218 | 51.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 13 | 13 | $585.00 | $231.23 | 39.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 111 | $11,145 | $7,154 | 64.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 80 | 80 | $11,600 | $5,618 | 48.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 36 | $5,275 | $3,222 | 61.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $4,095 | $2,479 | 60.5% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2021 | 24 | 27 | $1,215 | $429.84 | 35.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 11 | $660.00 | $429.80 | 65.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 74 | 83 | $4,980 | $2,686 | 53.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 12 | 12 | $11,940 | $2,328 | 19.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 51 | $4,335 | $2,216 | 51.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 16 | 16 | $11,440 | $1,358 | 11.9% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 26 | 26 | $2,470 | $1,198 | 48.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $2,175 | $988.99 | 45.5% |
| 43450 | Dilation of esophagus | Facility | 2020 | 14 | 14 | $3,500 | $442.40 | 12.6% |
About Dr. John Smiarowski, M.D
Dr. John Smiarowski, M.D is a Gastroenterology healthcare provider based in Monroe, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568462851.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Smiarowski, M.D has received a total of $7,792 in payments from pharmaceutical and medical device companies, with $949.30 received in 2024. These payments were reported across 391 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,722).
As a Medicare-enrolled provider, Smiarowski has provided services to 815 Medicare beneficiaries, totaling 879 services with total Medicare billing of $55,562. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Monroe, LA
- Active Since 07/28/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1568462851
Products in Payments
- XIFAXAN (Drug) $580.29
- TRULANCE (Drug) $515.85
- LINZESS (Drug) $429.33
- HUMIRA (Biological) $390.93
- Humira (Biological) $347.88
- RINVOQ (Biological) $343.67
- SKYRIZI (Biological) $329.32
- Trulance (Drug) $298.49
- ENTYVIO (Biological) $280.76
- ZEPOSIA (Drug) $257.75
- STELARA (Biological) $228.54
- ZENPEP (Drug) $211.18
- XELJANZ (Drug) $205.10
- APRISO (Drug) $190.34
- Olympus EndoTherapy Accessories (Device) $177.73
- INJECTAFER (Drug) $165.94
- CREON (Drug) $164.02
- GIMOTI (Drug) $150.32
- VOQUEZNA (Drug) $136.72
- Entyvio (Biological) $134.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Monroe
Stephen Stephenson, M.d, M.D
Gastroenterology — Payments: $21,253
Gastroenterology $21,253
Anthony Colvin, M.d, M.D
Gastroenterology — Payments: $12,242
Gastroenterology $12,242
Henry Hinkle, M.d, M.D
Gastroenterology — Payments: $12,040
Gastroenterology $12,040
Arthur Richert, M.d, M.D
Gastroenterology — Payments: $7,844
Gastroenterology $7,844
Christopher Oglesby, D.o, D.O
Gastroenterology — Payments: $4,649
Gastroenterology $4,649
Dr. Murthy Madhira, M.d, M.D
Gastroenterology — Payments: $2,734
Gastroenterology $2,734